gefitinib has been researched along with bms 708163 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (bms 708163) | Trials (bms 708163) | Recent Studies (post-2010) (bms 708163) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 46 | 5 | 43 |
| Protein | Taxonomy | gefitinib (IC50) | bms 708163 (IC50) |
|---|---|---|---|
| Presenilin-1 | Homo sapiens (human) | 0.0006 | |
| Presenilin-2 | Homo sapiens (human) | 0.0006 | |
| Gamma-secretase subunit APH-1B | Homo sapiens (human) | 0.0006 | |
| Nicastrin | Homo sapiens (human) | 0.0006 | |
| Gamma-secretase subunit APH-1A | Homo sapiens (human) | 0.0006 | |
| Gamma-secretase subunit PEN-2 | Homo sapiens (human) | 0.0006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, C; He, J; Wei, S; Xie, M | 1 |
1 other study(ies) available for gefitinib and bms 708163
| Article | Year |
|---|---|
γ Secretase inhibitor BMS-708163 reverses resistance to EGFR inhibitor via the PI3K/Akt pathway in lung cancer.
Topics: Amyloid Precursor Protein Secretases; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; ErbB Receptors; Female; Gefitinib; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Inbred BALB C; Oxadiazoles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Sulfonamides | 2015 |